HB 127Alabama
Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.
In committee
Jan 13, 2026: Read for the first time and referred to the House Committee on Health